PRLD(Prelude Therapeutics Incorporated) · 内部人交易

PRLD(Prelude Therapeutics Incorporated) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

PRLD 最近的内部人买卖(Form 4)
交易日姓名职务类型股数价格
2026-04-21Bonita David P董事、10% 股东公开市场买入1,126,126$4.44
2026-04-21Bonita David P董事、10% 股东公开市场买入1,689,189$4.44
2026-04-21ORBIMED ADVISORS LLC董事、10% 股东公开市场买入1,126,126$4.44
2026-04-21ORBIMED ADVISORS LLC董事、10% 股东公开市场买入1,689,189$4.44
2026-04-21BAKER BROS. ADVISORS LP董事、10% 股东公开市场买入2,137,651$4.44
2026-04-21BAKER BROS. ADVISORS LP董事、10% 股东公开市场买入114,601$4.44
2025-03-25Combs AndrewChief Chemistry Officer公开市场买入100,000$0.69
2025-03-25Vaddi KrishnaCEO公开市场买入675,000$0.69
2025-03-21Vaddi KrishnaCEO公开市场买入15,000$0.73
2025-03-20Vaddi KrishnaCEO公开市场买入5,416$0.73
2025-03-17Vaddi KrishnaCEO公开市场买入9,106$0.75
2025-03-14Vaddi KrishnaCEO公开市场买入29,999$0.75
2025-03-13Vaddi KrishnaCEO公开市场买入50,000$0.72
2025-03-12Vaddi KrishnaCEO公开市场买入47,500$0.71
2024-12-31Vaddi KrishnaCEO公开市场买入5,000$1.21
2024-12-30Vaddi KrishnaCEO公开市场买入10,000$1.20
2024-12-23Combs AndrewChief Chemistry Officer公开市场买入60,000$1.37
2024-12-20Combs AndrewChief Chemistry Officer公开市场买入3,075$1.15
2024-12-19Lim Bryant DavidCLO, Interim CFO, Corp Sec.公开市场买入25,000$0.91
2024-12-19Vaddi KrishnaCEO公开市场买入6,888$0.89

Prelude Therapeutics Incorporated PRLD